The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...

MDI Bio Lab scientists discover how the fish solves a basic challenge in regenerative biology-insights in their newest ...

A phase 2 trial shows rilparencel improves annual eGFR slope, which suggests the cell therapy may preserve kidney function in patients with diabetic nephropathy. Rilparencel, an investigational renal ...

Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective means to grow iPS cell-derived kidney progenitor cells, paving the way for ...

As concerns rise about the effects of tiny plastic particles on human health, Flinders University researchers have led new research on whether nanoplastics can accumulate or cause damage in kidneys – ...

Please provide your email address to receive an email when new articles are posted on . In an editorial published in the Clinical Journal of the American Society of Nephrology, nephrologists Mark E.

Chronic kidney disease (CKD) affects more than 10% of the global population and is expected to become the fifth leading cause of death worldwide within the next two decades. Perhaps surprisingly, ...

Stage 3 RCC involves tumor growth beyond the kidney, affecting nearby tissues or lymph nodes, but not distant organs. Diagnosis includes imaging, biopsy, and molecular testing to guide treatment ...